Genetic Test Now Available to Predict Radiation Therapy Side Effects in Prostate Cancer
PROSTOX ultra identifies patients at higher risk of developing late genitourinary toxicity from stereotactic body radiation therapy.
Category: Prostate
Prostate
Latest
Prostate
Latest
Why Genomic Tests for Prostate Cancer Need Better Data
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Prostate
Latest
Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Blood Test and MRI Combo Could Reduce Unnecessary Prostate Biopsies
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read More
Researchers Use Deep Learning to Diagnose Prostate Cancer
Researchers developed a deep-learning model to improve the 3D segmentation of glandular tissue structures for prostate cancer assessment.
Read More
AI Reveals Prostate Cancer is Not Just One Disease
AI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.Â
Read More
Oncobiomix Adopts AI-Based Disease Insights Platform for Prostate Cancer Test
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read More
AI Algorithm Promises to Improve Workflows at Ohio Cancer Center
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read More
Rectal Examinations Do Not Improve Prostate Cancer Screening Effectiveness
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read More
Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer
Researchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read More
ArteraAI Gets Medicare Payment Rate for Prostate Cancer Test
ArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read More
$3M Grant to Develop AI to Detect Aggressive Prostate Cancer
UCLA Researchers have received a five-year, $3 million grant to develop AI that can detect and predict aggressive prostate cancer.
Read More
Biomarker HSD3B1 Identified as Reason for Therapeutic Resistance
Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.Â
Read More
Black Men are More Likely to Have Prostate Cancer than White Men
Black men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.Â
Read More
ArteraAI Validates Prognostic Model in Advanced Prostate Cancer
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read More
New Algorithm Predicts Prostate Cancer Recurrence for Radiation Therapy Patients
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.Â
Read More
Precision Medicine Navigators Increase Genomic Testing Rates for Black Patients with Prostate Cancer
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read More
Detecting Metastatic Prostate Cancer Risk in Black Men
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read More